Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Imagery Control Therapy and Lucid Dreaming for REM-Related Symptoms in Narcolepsy

NCT07609537 is registered in ClinicalTrials.gov with Institute of Behavioral Sleep Medicine, Colombia as lead sponsor.

NCT NCT07609537
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07609537 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Imagery Control Therapy and Lucid Dreaming for REM-Related Symptoms in Narcolepsy
Lead sponsor
Institute of Behavioral Sleep Medicine, Colombia
Phase
Not applicable
Overall status
Completed
Start date
March 1, 2024
Completion date
June 15, 2025
Enrollment
98 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

central disorders of hypersomnolence, hypnagogic hallucinations, narcolepsy type 1, rem sleep intrusion symptoms, sleep paralysis